Article Text
Infographic
Liposomal bupivacaine versus bupivacaine hydrochloride: are we changing the outcomes?
Statistics from Altmetric.com
Abstract
Hanns-Christian et al 1 conducted a literature review with the objective of determining whether there is a difference in postoperative pain scores and opioid consumption between patients who received liposomal bupivacaine and patients who received bupivacaine hydrochloride.
The authors concluded that the beneficial effect on both postoperative pain scores and opioid consumption was small but not clinically relevant.1
Reference
Footnotes
Contributors AA-E designed and produced the infographic.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.